Rare diseases
Investigational molecules
Locations
Sophie-Germain-Strasse 10, 90443 Nürnberg, Germany
Research activity includes giant cell arteritis with attention to disease control in patients in clinical remission, relapse prevention, and treatment strategies built around glucocorticoid-sparing care. The therapeutic focus extends to inflammatory pathways relevant to large-vessel vasculitis and sustained suppression of disease activity.
The sponsor’s work in this area reflects interest in managing chronic immune-mediated vascular inflammation and improving long-term symptom stability.
Novartis Pharma GmbH runs clinical trials in conditions such as Giant cell arteritis, Hypercholesterolaemia, Polycythaemia vera, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
GermanyGermanyGermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
